VCAN, expressed highly in hepatitis B virus-induced hepatocellular carcinoma, is a potential biomarker for immune checkpoint inhibitors

Figure 2 VCAN mRNA expression in tumor tissue and adjacent tissue in The Cancer Genome Atlas Liver Hepatocellular Carcinoma. A: VCAN mRNA expression in different types of tumors; B: VCAN mRNA expression in 374 tumor tissues and 50 normal tissues from The Cancer Genome Atlas Liver Hepatocellular Carcinoma (TCGA-LIHC); C: VCAN mRNA expression in 50 paired tumor tissues and normal tissues from TCGA-LIHC; D: Kaplan-Meier analysis for low VCAN and high VCAN expression (median as cutoff) in TCGA-LIHC. ^aP < 0.05, ^bP < 0.01, ^cP < 0.001. TPM: Transcripts per kilobase of exon model per million mapped reads; HR: Hazard ratio.